Page last updated: 2024-12-05

metiazinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

metiazinic acid: phenothiazine which acts as an anti-inflammatory agent; minor descriptor (75-86); on line & INDEX MEDICUS search PHENOTHIAZINES (75-86) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

metiazinic acid : Phenothiazine substituted at nitrogen by a methyl group and at C-2 by a carboxymethyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID4164
CHEMBL ID2105269
CHEBI ID31838
SCHEMBL ID150554
MeSH IDM0263230

Synonyms (48)

Synonym
acide metiazinique
acidum metiazinicum
CHEBI:31838 ,
acido metiazinico
metiazinic acid
(10-methyl-10h-phenothiazin-2-yl)acetic acid
roimal
soripal
acide metiazinique [french]
(10-methyl-2-phenothiazinyl)acetic acid
methiazinic acid
acido metiazinico [inn-spanish]
n-methyl-3-phenothiazinylacetic acid
rp 16091
acidum metiazinicum [inn-latin]
rp 16,091
10-methylphenothiazine-2-acetic acid
bayer 4512
2-(10-methyl-2-phenothiazinyl)essigsaeure
soridermal
acide metiazinique [inn-french]
einecs 237-795-0
phenothiazine-2-acetic acid, 10-methyl-
ambrunate
metiazinic acid [inn:dcf:jan]
D01189
metiazinic acid (jan/inn)
13993-65-2
2-(10-methylphenothiazin-2-yl)acetic acid
unii-12i0hhe2zy
12i0hhe2zy ,
CHEMBL2105269
rp-16091
EPITOPE ID:139983
AKOS022507510
SCHEMBL150554
LMINNBXUMGNKMM-UHFFFAOYSA-N
metiazinic acid [who-dd]
metiazinic acid [mi]
metiazinic acid [mart.]
metiazinic acid [inn]
10-methyl-2-phenothiazinyl acetic acid
metiazinic acid [jan]
DTXSID7023308
Q27114694
bdbm50462865
metiazinicacid
2-(10-methyl-10h-phenothiazin-2-yl)acetic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
non-steroidal anti-inflammatory drugAn anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
drug allergenAny drug which causes the onset of an allergic reaction.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenothiazines
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prostaglandin G/H synthase 1Ovis aries (sheep)IC50 (µMol)6.23000.00032.177410.0000AID1397088
Prostaglandin G/H synthase 2Ovis aries (sheep)IC50 (µMol)10.45000.00101.453910.0000AID1397089
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1397089Inhibition of ovine COX2 assessed as reduction in PGH2 production by enzyme immunoassay2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Synthesis and biological properties of aryl methyl sulfones.
AID1397090Selectivity ratio of IC50 for ovine COX1 to IC50 for ovine COX22018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Synthesis and biological properties of aryl methyl sulfones.
AID1397088Inhibition of ovine COX1 assessed as reduction in PGH2 production by enzyme immunoassay2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Synthesis and biological properties of aryl methyl sulfones.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]